Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Atheroprotective Effects of Tumor Necrosis Factor-Stimulated Gene-6.

Watanabe R, Watanabe H, Takahashi Y, Kojima M, Konii H, Watanabe K, Shirai R, Sato K, Matsuyama TA, Ishibashi-Ueda H, Iso Y, Koba S, Kobayashi Y, Hirano T, Watanabe T.

JACC Basic Transl Sci. 2016 Oct 31;1(6):494-509. doi: 10.1016/j.jacbts.2016.07.008. eCollection 2016 Oct.

2.

Inhibitory effects of vasostatin-1 against atherogenesis.

Sato Y, Watanabe R, Uchiyama N, Ozawa N, Takahashi Y, Shirai R, Sato K, Mori Y, Matsuyama T, Ishibashi-Ueda H, Hirano T, Watanabe T.

Clin Sci (Lond). 2018 Dec 5;132(23):2493-2507. doi: 10.1042/CS20180451. Print 2018 Dec 12.

PMID:
30401690
3.

Novel phytopeptide osmotin mimics preventive effects of adiponectin on vascular inflammation and atherosclerosis.

Takahashi Y, Watanabe R, Sato Y, Ozawa N, Kojima M, Watanabe-Kominato K, Shirai R, Sato K, Hirano T, Watanabe T.

Metabolism. 2018 Jun;83:128-138. doi: 10.1016/j.metabol.2018.01.010. Epub 2018 Feb 2.

PMID:
29410350
4.

Counteractive effects of omentin-1 against atherogenesis†.

Watanabe K, Watanabe R, Konii H, Shirai R, Sato K, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.

Cardiovasc Res. 2016 May 1;110(1):118-28. doi: 10.1093/cvr/cvw016. Epub 2016 Jan 19.

PMID:
26790473
5.

Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia.

Kojima M, Ozawa N, Mori Y, Takahashi Y, Watanabe-Kominato K, Shirai R, Watanabe R, Sato K, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.

Thromb Haemost. 2018 Jan;118(1):182-194. doi: 10.1160/TH17-05-0349. Epub 2018 Jan 5.

PMID:
29304538
6.

Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.

Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.

J Am Heart Assoc. 2017 Apr 14;6(4). pii: e005790. doi: 10.1161/JAHA.117.005790.

7.

Facilitatory effects of fetuin-A on atherosclerosis.

Naito C, Hashimoto M, Watanabe K, Shirai R, Takahashi Y, Kojima M, Watanabe R, Sato K, Iso Y, Matsuyama TA, Suzuki H, Ishibashi-Ueda H, Watanabe T.

Atherosclerosis. 2016 Mar;246:344-51. doi: 10.1016/j.atherosclerosis.2016.01.037. Epub 2016 Jan 22. Erratum in: Atherosclerosis. 2016 Oct;253:346.

PMID:
26828753
8.

Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration.

Yamamoto K, Tajima Y, Hasegawa A, Takahashi Y, Kojima M, Watanabe R, Sato K, Shichiri M, Watanabe T.

Peptides. 2016 Aug;82:120-127. doi: 10.1016/j.peptides.2016.06.009. Epub 2016 Jun 21.

PMID:
27346255
9.

Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.

Sato K, Shirai R, Yamaguchi M, Yamashita T, Shibata K, Okano T, Mori Y, Matsuyama TA, Ishibashi-Ueda H, Hirano T, Watanabe T.

Int J Mol Sci. 2018 Jun 11;19(6). pii: E1732. doi: 10.3390/ijms19061732.

10.

Neopterin Counters Vascular Inflammation and Atherosclerosis.

Shirai R, Sato K, Yamashita T, Yamaguchi M, Okano T, Watanabe-Kominato K, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.

J Am Heart Assoc. 2018 Feb 2;7(3). pii: e007359. doi: 10.1161/JAHA.117.007359.

11.

Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis.

Sato K, Yoshizawa H, Seki T, Shirai R, Yamashita T, Okano T, Shibata K, Wakamatsu MJ, Mori Y, Morita T, Matsuyama TA, Ishibashi-Ueda H, Hirano T, Watanabe T.

Clin Sci (Lond). 2019 Aug 20;133(16):1779-1796. doi: 10.1042/CS20190336. Print 2019 Aug 30.

PMID:
31399499
12.

Emerging Roles of Tumor Necrosis Factor-Stimulated Gene-6 in the Pathophysiology and Treatment of Atherosclerosis.

Watanabe R, Sato Y, Ozawa N, Takahashi Y, Koba S, Watanabe T.

Int J Mol Sci. 2018 Feb 5;19(2). pii: E465. doi: 10.3390/ijms19020465. Review.

13.

Legumain Promotes Atherosclerotic Vascular Remodeling.

Ozawa N, Sato Y, Mori Y, Masuda H, Yamane M, Yamamoto Y, Shirai R, Watanabe R, Sato K, Mori Y, Hirano T, Watanabe T.

Int J Mol Sci. 2019 May 4;20(9). pii: E2195. doi: 10.3390/ijms20092195.

14.

Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.

Hasegawa A, Sato K, Shirai R, Watanabe R, Yamamoto K, Watanabe K, Nohtomi K, Hirano T, Watanabe T.

PLoS One. 2014 Dec 2;9(12):e110866. doi: 10.1371/journal.pone.0110866. eCollection 2014.

15.

Stimulatory effects of cardiotrophin 1 on atherosclerosis.

Konii H, Sato K, Kikuchi S, Okiyama H, Watanabe R, Hasegawa A, Yamamoto K, Itoh F, Hirano T, Watanabe T.

Hypertension. 2013 Nov;62(5):942-50. doi: 10.1161/HYPERTENSIONAHA.113.01653. Epub 2013 Sep 16.

PMID:
24041953
16.

Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation.

Sato K, Yamashita T, Shirai R, Shibata K, Okano T, Yamaguchi M, Mori Y, Hirano T, Watanabe T.

Int J Mol Sci. 2018 Apr 26;19(5). pii: E1293. doi: 10.3390/ijms19051293.

17.

Postprandial lipoproteins and the molecular regulation of vascular homeostasis.

Botham KM, Wheeler-Jones CP.

Prog Lipid Res. 2013 Oct;52(4):446-64. doi: 10.1016/j.plipres.2013.06.001. Epub 2013 Jun 15. Review.

PMID:
23774609
18.

A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis.

Tashiro Y, Sato K, Watanabe T, Nohtomi K, Terasaki M, Nagashima M, Hirano T.

Peptides. 2014 Apr;54:19-26. doi: 10.1016/j.peptides.2013.12.015. Epub 2014 Jan 10.

PMID:
24418070
19.

Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.

Xu G, Watanabe T, Iso Y, Koba S, Sakai T, Nagashima M, Arita S, Hongo S, Ota H, Kobayashi Y, Miyazaki A, Hirano T.

Circ Res. 2009 Aug 28;105(5):500-10. doi: 10.1161/CIRCRESAHA.109.193870. Epub 2009 Jul 30.

PMID:
19644050
20.

Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.

Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T.

Atherosclerosis. 2010 Sep;212(1):70-7. doi: 10.1016/j.atherosclerosis.2010.04.027. Epub 2010 May 4.

PMID:
20684826

Supplemental Content

Support Center